Avacta Group (LON:AVCT) Trading Down 13.2% – Here’s Why

Avacta Group Plc (LON:AVCT) shares were down 13.2% during mid-day trading on Tuesday . The stock traded as low as GBX 33 ($0.43) and last traded at GBX 33 ($0.43). Approximately 2,673,765 shares traded hands during trading, an increase of 96% from the average daily volume of 1,364,946 shares. The stock had previously closed at GBX 38 ($0.49).

Avacta Group Price Performance

The stock has a market capitalization of £140.88 million, a PE ratio of -4.77 and a beta of 1.12. The company’s 50 day simple moving average is GBX 46.74 and its 200 day simple moving average is GBX 53.03. The company has a current ratio of 1.29, a quick ratio of 4.96 and a debt-to-equity ratio of 52.53.

Avacta Group Company Profile

Avacta Therapeutics is a clinical stage biopharmaceutical company challenging current drug delivery methods to expand the utility of highly potent cancer therapeutics.
The Company benefits from a world class research and development facility, team of exceptionally talented scientists and a highly experienced management team with members located in both the London headquarters and the US.

Our proprietary pre|CISION® platform masks toxic warheads by binding them to a short, engineered peptide that is cleavable only by the tumor-specific protease, fibroblast activation protein (FAP).